Breaking the shield that protects pancreatic cancer from immunotherapy

Scar-like cells that make up a sizable portion of malignant pancreatic tumors and shield these cancers from immune attack are derived from mesothelial cells that line tissues and organs, a new study suggests. The findings could offer a new strategy to fight pancreatic cancer, a deadly disease for which no truly effective treatments exist.